Published in N Engl J Med on January 30, 1992
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65
Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ (1996) 4.80
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother (1999) 2.73
Method of physician remuneration and rates of antibiotic prescription. CMAJ (1999) 2.60
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother (1997) 1.97
Influence of prescription patterns in general practice on anti-microbial resistance in Norway. Br J Gen Pract (1999) 1.95
Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother (1999) 1.64
Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol (1999) 1.59
Reconsidering sore throats. Part I: Problems with current clinical practice. Can Fam Physician (1997) 1.58
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother (2000) 1.57
Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda. Afr Health Sci (2007) 1.49
Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerg Infect Dis (1997) 1.49
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemother (1993) 1.39
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis (1998) 1.30
Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J Clin Microbiol (2003) 1.23
Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother (2004) 1.16
Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol (2003) 1.10
Global surveillance of antibiotic resistance. N Engl J Med (1992) 1.09
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother (1993) 1.06
Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol (2002) 1.02
High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J Clin Microbiol (2000) 1.00
A one-year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect (1992) 1.00
emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol (2003) 0.99
Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J Clin Microbiol (2005) 0.97
DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci. Antimicrob Agents Chemother (2006) 0.97
Use of flow cytometry for the adhesion analysis of Streptococcus pyogenes mutant strains to epithelial cells: investigation of the possible role of surface pullulanase and cysteine protease, and the transcriptional regulator Rgg. BMC Microbiol (2006) 0.97
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Antimicrob Agents Chemother (2005) 0.96
Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden. J Clin Microbiol (2001) 0.95
Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis (2000) 0.94
In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 0.94
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother (2001) 0.92
Group A Streptococcus: a re-emergent pathogen. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1993) 0.86
Ribosomal Resistance: Emerging Problems and Potential Solutions. Curr Infect Dis Rep (1999) 0.85
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob Agents Chemother (2003) 0.85
National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites. J Clin Microbiol (2003) 0.82
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010. Int J Infect Dis (2012) 0.82
Why use erythromycin? Thorax (1994) 0.82
Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec. Can J Infect Dis (1999) 0.80
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. Eur J Clin Microbiol Infect Dis (1997) 0.79
Throat swab culture & sensitivity reports - an overview. Indian J Otolaryngol Head Neck Surg (2003) 0.77
The effect of erythromycin on resolution of symptoms among adults with pharyngitis not caused by group A streptococcus. J Gen Intern Med (1997) 0.75
The Mysteries of Streptococcal Pharyngitis. Curr Treat Options Pediatr (2015) 0.75
Survey of Spanish general practitioners' attitudes toward management of sore throat: an internet-based questionnaire study. BMC Fam Pract (2017) 0.75
covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus. PLoS One (2015) 0.75
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med (1998) 8.47
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet (1983) 5.31
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet (2001) 4.39
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med (2000) 4.29
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet (1997) 4.27
Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00
Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol (2000) 3.98
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother (1988) 3.65
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology (2000) 3.01
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Diphtheria after visit to Russia. Lancet (1993) 2.74
Asthma programme in Finland: a community problem needs community solutions. Thorax (2001) 2.68
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care (1995) 2.44
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology (2000) 2.36
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28
Education and dementia: what lies behind the association? Neurology (2007) 2.26
Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax (2000) 2.25
Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22
Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol (1993) 2.22
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis (2004) 2.20
Invasive group A streptococcal infections. N Engl J Med (1996) 2.16
Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J (2001) 2.14
A 10 year asthma programme in Finland: major change for the better. Thorax (2006) 2.13
Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res (2001) 2.12
Cross-reactivity between Chlamydiazyme and Acinetobacter strains. N Engl J Med (1986) 2.09
Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet (2000) 2.08
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08
Rapid decrease in tuberculin skin test reactivity at preschool age after newborn vaccination. Acta Paediatr (1992) 2.03
Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol (1995) 2.00
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol (2001) 1.85
Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol (1985) 1.84
The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem (1990) 1.83
Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. The Finnish cohorts of the Seven Countries Study. Arch Intern Med (1989) 1.82
Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg (1992) 1.81
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology (2007) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry (2005) 1.79
Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women. Diabetologia (2003) 1.79
Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet (1999) 1.79
LKB1 somatic mutations in sporadic tumors. Am J Pathol (1999) 1.79
Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax (2001) 1.76
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Conventional identification characteristics, mycolate and fatty acid composition, and clinical significance of MAIX AccuProbe-positive isolates of Mycobacterium avium complex. J Clin Microbiol (1993) 1.74
Ten years of the North Karelia Project: results with community-based prevention of coronary heart disease. Scand J Soc Med (1983) 1.71
Mycobacterium branderi sp. nov., a new potential human pathogen. Int J Syst Bacteriol (1995) 1.71
Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J (1997) 1.68
Upper gastrointestinal tract polyps in familial adenomatosis coli. Gut (1983) 1.67
Justification of diagnostic medical exposures: some practical issues. Report of an International Atomic Energy Agency Consultation. Br J Radiol (2011) 1.66
Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. BMJ (1997) 1.66
Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet (1990) 1.65
Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J (2000) 1.63
Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy (1999) 1.63
Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest (1996) 1.61
Osteitis caused by bacille Calmette-Guérin vaccination: a retrospective analysis of 222 cases. J Infect Dis (1995) 1.61
Immunoprecipitating factors of vaccinia virus. Virology (1965) 1.60
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59
Late-onset lower motor neuronopathy: a new autosomal dominant disorder. Neurology (2011) 1.57
LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.56
Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med (1999) 1.56
Physical activity in relation to cognitive decline in elderly men: the FINE Study. Neurology (2004) 1.56
Rheumatic symptoms in the middle-aged population in southwestern Finland. Scand J Rheumatol Suppl (1982) 1.55
Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens (2000) 1.53
Salmonella in alfalfa sprouts. Lancet (1995) 1.52
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study. Hum Reprod (2012) 1.52
Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly. Eur Heart J (2001) 1.51
Separation among species of Mycobacterium terrae complex by lipid analyses: comparison with biochemical tests and 16S rRNA sequencing. J Clin Microbiol (1998) 1.51
Acute childhood asthma in Finland: a retrospective review of hospital admissions from 1976 to 1995. Pediatr Allergy Immunol (2000) 1.50
Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer (2000) 1.49
Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax (1996) 1.48
The latex agglutination test for the diagnosis of meningococcal and haemophilus influenzae meningitis. Scand J Infect Dis (1977) 1.47
Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med (2001) 1.47
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res (1997) 1.47
Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study. Scand J Infect Dis (1996) 1.46
Cost-effectiveness of the North Karelia Hypertension Program. 1972-1977. Med Care (1986) 1.46
Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up. J Cardiovasc Risk (1996) 1.46
Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis (1976) 1.44